Modification of genetic damage by dihomo-gamma-linolenic acid.
Sridevi
K
K
Clinical Cancer Center, University of Wisconsin, Madison 53792.
Rao
K P
KP
D015126:8,11,14-Eicosatrienoic Acid / Q000494:pharmacology*; D000818:Animals; D016587:Antimutagenic Agents / Q000494:pharmacology*; D001564:Benzo(a)pyrene / Q000633:toxicity; D002869:Chromosome Aberrations / Q000235:genetics; D004913:Erythrocytes, Abnormal / Q000187:drug effects; D008214:Lymphocytes / Q000187:drug effects / Q000378:metabolism; D051379:Mice; D015162:Micronucleus Tests; D009153:Mutagens / Q000633:toxicity*; D013755:Tetradecanoylphorbol Acetate / Q000633:toxicity*; D013936:Thymidine / Q000378:metabolism; D013997:Time Factors
D016587:Antimutagenic Agents; D009153:Mutagens; D001564:Benzo(a)pyrene; D015126:8,11,14-Eicosatrienoic Acid; D013755:Tetradecanoylphorbol Acetate; D013936:Thymidine